KR850002477A - 4-(3-알키닐옥시-2-하이드록시-프로필)-피퍼라진-1-일-n-페닐-아세트아미드 유도체의 제조방법 - Google Patents
4-(3-알키닐옥시-2-하이드록시-프로필)-피퍼라진-1-일-n-페닐-아세트아미드 유도체의 제조방법 Download PDFInfo
- Publication number
- KR850002477A KR850002477A KR1019840005613A KR840005613A KR850002477A KR 850002477 A KR850002477 A KR 850002477A KR 1019840005613 A KR1019840005613 A KR 1019840005613A KR 840005613 A KR840005613 A KR 840005613A KR 850002477 A KR850002477 A KR 850002477A
- Authority
- KR
- South Korea
- Prior art keywords
- phenyl
- lower alkyl
- formula
- hydrogen
- radical
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (4)
- 하기식(A) 또는 그염과 하기식(D)에 따른 적당히 치환된 N-페닐-할로게노아세트아미드가 알카리물질 존재하에서 반응되는 것을 특징으로 하는 하기식(I)의 화합물을 제조하는 방법.
- 제1항에 있어서, 칼륨카보네이트 또는 트리에틸아민이 알카리물질로 사용되는 것을 특징으로 하는 방법.
- 제1항에 있어서, 하기식(C) 또는 그염과 하기식 (D)가 무수물 유기용매내에서 반응하는 것을 특징으로 하는 방법.
- 활성성분으로서 적어도 하나의 하기식(I)화합물을 적당한 부형제와 혼합하여 포함하는 것을 특징으로 하는 심장질환치료에 특히 유용한 약학적 조성물.여기서, R1은 수소 또는 저급알킬라디칼, R2와 R3는 각각 페닐라디칼 또는 저급알킬라디칼이며 이것이 부착되어 있는 탄소원자는 사이크로알킬 라디칼이고, R4는 수소 또는 저급알킬라디칼, R5는 할로겐원자에 의해 임의로 치환된 저급알킬라디칼 또는 페닐라디칼이고, X는 수소 또는 할로겐원자와 약학적으로 허용되는 산부가염이며, "Hal"는 할로겐 특히 염소 또는 브롬이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8314720 | 1983-09-15 | ||
FR8314720A FR2552083B1 (fr) | 1983-09-15 | 1983-09-15 | Derives de (alkynyloxy-3 hydroxy-2-propyl)-4 piperazinyl-1 n-phenyl acetamide, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
KR850002477A true KR850002477A (ko) | 1985-05-13 |
Family
ID=9292262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840005613A KR850002477A (ko) | 1983-09-15 | 1984-09-14 | 4-(3-알키닐옥시-2-하이드록시-프로필)-피퍼라진-1-일-n-페닐-아세트아미드 유도체의 제조방법 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0143016B1 (ko) |
JP (1) | JPS60142972A (ko) |
KR (1) | KR850002477A (ko) |
AT (1) | ATE28639T1 (ko) |
AU (1) | AU572888B2 (ko) |
DE (1) | DE3465085D1 (ko) |
DK (1) | DK439384A (ko) |
ES (2) | ES535899A0 (ko) |
FI (1) | FI77243C (ko) |
FR (1) | FR2552083B1 (ko) |
GR (1) | GR80359B (ko) |
HU (1) | HU192994B (ko) |
PT (1) | PT79214B (ko) |
ZA (1) | ZA846937B (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451798B2 (en) | 2000-02-22 | 2002-09-17 | Cv Therapeutics, Inc. | Substituted alkyl piperazine derivatives |
US6677336B2 (en) | 2000-02-22 | 2004-01-13 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
US6552023B2 (en) | 2000-02-22 | 2003-04-22 | Cv Therapeutics, Inc. | Aralkyl substituted piperazine compounds |
EP1259493A2 (en) * | 2000-02-22 | 2002-11-27 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
US6693099B2 (en) * | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
WO2008120235A1 (en) * | 2007-03-30 | 2008-10-09 | Council Of Scientific & Industrial Research | Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof |
JP6077344B2 (ja) * | 2013-03-12 | 2017-02-08 | 花王株式会社 | ピペラジン誘導体を含む漂白剤組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2173869B1 (ko) * | 1972-04-13 | 1975-12-26 | Cerm Cent Europ Rech Mauvernay | |
US3951979A (en) * | 1972-04-13 | 1976-04-20 | Roland Yves Mauvernary | New amino propanediol derivatives |
FR2403330A1 (fr) * | 1977-06-16 | 1979-04-13 | Fabre Sa Pierre | Nouveaux derives de benzoyl-2-chloro-4-glycinanilides substitues, leur procede de preparation et leur application en tant que medicaments |
-
1983
- 1983-09-15 FR FR8314720A patent/FR2552083B1/fr not_active Expired
-
1984
- 1984-09-04 ZA ZA846937A patent/ZA846937B/xx unknown
- 1984-09-10 AU AU32861/84A patent/AU572888B2/en not_active Ceased
- 1984-09-13 JP JP59192411A patent/JPS60142972A/ja active Pending
- 1984-09-13 GR GR80359A patent/GR80359B/el unknown
- 1984-09-13 ES ES535899A patent/ES535899A0/es active Granted
- 1984-09-14 PT PT79214A patent/PT79214B/pt unknown
- 1984-09-14 DE DE8484401824T patent/DE3465085D1/de not_active Expired
- 1984-09-14 FI FI843617A patent/FI77243C/fi not_active IP Right Cessation
- 1984-09-14 HU HU843473A patent/HU192994B/hu not_active IP Right Cessation
- 1984-09-14 EP EP84401824A patent/EP0143016B1/fr not_active Expired
- 1984-09-14 AT AT84401824T patent/ATE28639T1/de not_active IP Right Cessation
- 1984-09-14 DK DK439384A patent/DK439384A/da not_active Application Discontinuation
- 1984-09-14 KR KR1019840005613A patent/KR850002477A/ko not_active Application Discontinuation
-
1985
- 1985-07-05 ES ES544919A patent/ES8607265A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PT79214A (en) | 1984-10-01 |
AU3286184A (en) | 1985-03-21 |
FI843617A0 (fi) | 1984-09-14 |
FI77243B (fi) | 1988-10-31 |
PT79214B (en) | 1986-08-22 |
DE3465085D1 (en) | 1987-09-03 |
ES8602724A1 (es) | 1985-12-01 |
JPS60142972A (ja) | 1985-07-29 |
EP0143016B1 (fr) | 1987-07-29 |
ATE28639T1 (de) | 1987-08-15 |
DK439384A (da) | 1985-03-16 |
HU192994B (en) | 1987-08-28 |
ZA846937B (en) | 1985-04-24 |
GR80359B (en) | 1985-01-11 |
EP0143016A1 (fr) | 1985-05-29 |
FI843617L (fi) | 1985-03-16 |
DK439384D0 (da) | 1984-09-14 |
ES544919A0 (es) | 1986-05-16 |
FI77243C (fi) | 1989-02-10 |
AU572888B2 (en) | 1988-05-19 |
FR2552083B1 (fr) | 1986-05-09 |
HUT35253A (en) | 1985-06-28 |
FR2552083A1 (fr) | 1985-03-22 |
ES8607265A1 (es) | 1986-05-16 |
ES535899A0 (es) | 1985-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7909392L (sv) | Nya substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner | |
DK623586D0 (da) | Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne | |
KR840007596A (ko) | 유기인 유도체의염의 제조방법 | |
KR920701177A (ko) | 3-아릴옥사졸리디논 유도체, 그의 제조 방법 및 그의 치료 용도 | |
IL85315A (en) | 3-(2,3-dimethyl-3-(2,3,5,6-tetrafluoro-benzyloxycarbonyl)-1-cyclopropyl)-2-propenoic acid esters,process for the preparation thereof and application thereof to pest control | |
KR850002477A (ko) | 4-(3-알키닐옥시-2-하이드록시-프로필)-피퍼라진-1-일-n-페닐-아세트아미드 유도체의 제조방법 | |
RU94026094A (ru) | Применение феналкиламинов | |
SE7605819L (sv) | Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav | |
KR920007995A (ko) | 벤즈아미드 유도체 | |
KR930700502A (ko) | 6-아미노옥타히드로인돌리진트리올 유도체 | |
KR910009266A (ko) | 수의학 약제로서 유용한 피리돈-카르복실산 유도체 | |
KR840003631A (ko) | 아졸릴펜옥시- 테트라하이드로푸란-2-일리덴- 메탄의 제조방법 | |
KR890006621A (ko) | 항불안제 | |
ATE14428T1 (de) | Verfahren zur herstellung von bromhaltigen 1,3dioxolen-2-ones. | |
KR890002103A (ko) | 피페리딘 유도체, 그의제법 및 도르지발 38 | |
SE7903687L (sv) | Cyklohexylkarboxylsyraderivat och sett att framstella desamma | |
KR890002111A (ko) | 벤즈이미다졸 유도체, 그의 제법 및 치료에의 이용 | |
KR850007590A (ko) | 4-(니트로페닐)-테트라히드로피리딘류의 제조방법 | |
ATE146481T1 (de) | Epoxysuccinamidsäurederivat | |
KR840006810A (ko) | 세팔로스포린 에스테르의 제조방법 | |
NO164474C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater. | |
ATE3146T1 (de) | Neue 1-aryloxy-3-alkylamino-2-propanole und verfahren zu ihrer herstellung. | |
KR940021524A (ko) | 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법 | |
JPS554392A (en) | Imidazole derivative and medical composition | |
KR920004334A (ko) | 광학적 활성 알라닌아닐리드 화합물의 산부가염 및 그것을 함유하는 약학적조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |